[Drug Vial Optimization(DVO)for Anti-Cancer Drugs].
The healthcare cost reduction is one of the big national issues in Japan. The author published a policy report on drug vial optimization(DVO)as a concrete solution to reduce the healthcare cost. 31.9 billion Japanese Yen(JPY)to 41.0 billion JPY can be reduced if DVOis introduced all over Japan and this reduction amount must be bigger now since the anti-cancer drug market is growing every year and expensive anti-cancer drugs have been newly introduced in the market. The author made discussion with various people in mass media and stakeholders of policies and investigation to introduce DVOin Japan was started. Also, some hospitals started to investigate and introduce DVOindependently. According to open information, National Cancer Center Hospital(NCCH)started to introduce DVOfor 1 anti-cancer drug and Kagoshima University Hospital reported the simulation results for DVO. It is expected that policies will be built so that the independent action done by each hospital will be standard actions for all the hospitals in Japan. The market size of medical drugs grew to about 10.6 trillion JPY in 2015 and various drugs are discarded both inside and outside hospitals. Thus, there are various opportunities and methods besides DVOto reduce the healthcare cost. The author expects that various organizations will propose various methods to reduce the healthcare cost.